Researchers at the University of Cologne have discovered a possible therapeutic approach to treat diabetic nerve damage. The study found that a protein called p35 accumulates in nerve cells, blocking the regrowth of nerve fibres. By targeting this protein, the team developed peptides that can increase nerve regeneration in diabetic mice, improving motor and sensory functions.